Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 38.84 Million USD | -67.7% |
| 2022 | 120.26 Million USD | -4.96% |
| 2021 | 126.53 Million USD | -12.03% |
| 2020 | 143.84 Million USD | 36.81% |
| 2019 | 105.13 Million USD | 2.63% |
| 2018 | 102.44 Million USD | 138.91% |
| 2017 | 42.88 Million USD | -29.4% |
| 2016 | 60.73 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 99.22 Million USD | -17.49% |
| 2023 Q2 | 72.35 Million USD | -27.08% |
| 2023 FY | 38.84 Million USD | -67.7% |
| 2023 Q3 | 55.65 Million USD | -23.09% |
| 2023 Q4 | 38.84 Million USD | -30.2% |
| 2022 Q3 | 143.74 Million USD | -12.19% |
| 2022 Q1 | 153.32 Million USD | 21.17% |
| 2022 FY | 120.26 Million USD | -4.96% |
| 2022 Q4 | 120.26 Million USD | -16.33% |
| 2022 Q2 | 163.69 Million USD | 6.76% |
| 2021 Q2 | 156.83 Million USD | 0.0% |
| 2021 FY | 126.53 Million USD | -12.03% |
| 2021 Q4 | 126.53 Million USD | -9.79% |
| 2021 Q3 | 140.27 Million USD | -10.56% |
| 2020 FY | 143.84 Million USD | 36.81% |
| 2019 FY | 105.13 Million USD | 2.63% |
| 2018 FY | 102.44 Million USD | 138.91% |
| 2017 FY | 42.88 Million USD | -29.4% |
| 2016 FY | 60.73 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -1681588.312% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -1883.823% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -268.078% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -6935.97% |
| Rebus Holdings, Inc. | 5000.00 USD | -776840.0% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 70.166% |
| Qrons Inc. | 420.00 USD | -9249185.714% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -4940.849% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -39.017% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -7983.744% |
| Skye Bioscience, Inc. | 11.94 Million USD | -225.341% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -438.065% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -50777.492% |
| SQZ Biotechnologies Company | 107.18 Million USD | 63.758% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -2612.719% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -53582.029% |
| Mesoblast Limited | 667.9 Million USD | 94.184% |
| Marizyme, Inc. | 22.01 Million USD | -76.456% |
| Genus plc | 1.02 Billion USD | 96.224% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -2759.86% |
| Pharming Group N.V. | 462.85 Million USD | 91.607% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -1072.558% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -7684.362% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -6095.694% |
| ContraFect Corporation | 20.67 Million USD | -87.857% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -9851.43% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -10064.662% |
| IMV Inc. | 31.33 Million USD | -23.978% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -836.97% |
| MultiCell Technologies, Inc. | 126.22 USD | -30777114.388% |
| ONE Bio Corp. | 70.08 Million USD | 44.572% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -4034.027% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 69.771% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -8898.318% |
| Q BioMed Inc. | 3.51 Million USD | -1005.015% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -10.427% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -14768.128% |
| Biomind Labs Inc. | 73.81 Thousand USD | -52524.663% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 91.296% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -2581.243% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -29.425% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -1314.503% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -5550.588% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -1392.281% |
| GB Sciences, Inc. | 103.44 Thousand USD | -37454.378% |
| Alpha Cognition Inc. | 2.45 Million USD | -1484.189% |
| HST Global, Inc. | 1526.00 USD | -2545574.967% |
| CSL Limited | 38.02 Billion USD | 99.898% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -3832.014% |
| Halberd Corporation | 10.13 Thousand USD | -383346.846% |
| Enzolytics Inc. | 361.7 Million USD | 89.26% |
| Agentix Corp. | 261.39 Thousand USD | -14761.587% |
| Resverlogix Corp. | 8.11 Million USD | -378.706% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -1968.663% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.145% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 18.563% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -5973.108% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -170423.682% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -334.086% |
| AVAX Technologies, Inc. | 7.37 Million USD | -426.585% |
| Zenith Capital Corp. | 7410.00 USD | -524151.012% |
| Genscript Biotech Corporation | 3.38 Billion USD | 98.853% |
| Ember Therapeutics, Inc. | 184.00 USD | -21112400.0% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -11971.559% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -14763.179% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -4086.275% |
| Kadimastem Ltd | 2.3 Million USD | -1586.009% |
| Helix BioMedix, Inc. | 3.02 Million USD | -1184.162% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 26.288% |
| BioStem Technologies, Inc. | 14.56 Million USD | -166.801% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -67940.425% |
| LadRx Corporation | 2.3 Million USD | -1583.232% |
| Cell Source, Inc. | 195.17 Thousand USD | -19804.084% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -10885.614% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -10885.614% |
| NovAccess Global Inc. | 62.24 Thousand USD | -62306.824% |
| Affymax, Inc. | 7.44 Million USD | -421.927% |
| Itoco Inc. | 1.4 Million USD | -2674.643% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -40510.724% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -36548.113% |
| Mobile Lads Corp. | 52.00 USD | -74705669.231% |
| CytoDyn Inc. | 11.13 Million USD | -248.842% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -27071.054% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -217165.101% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -9977.801% |
| SYBLEU INC | 330.46 Thousand USD | -11655.147% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -9388.254% |
| International Stem Cell Corporation | 5.39 Million USD | -620.724% |
| Bioxytran, Inc. | 137.63 Thousand USD | -28124.037% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -158.948% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -134.314% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -49073.418% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -4392.66% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -416.789% |
| Neutra Corp. | 2851.00 USD | -1362474.535% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -19.876% |
| PureTech Health plc | 693.97 Million USD | 94.402% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -381.311% |
| IXICO plc | 15.84 Million USD | -145.186% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -369.053% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 62.403% |
| CSL Limited | 38.02 Billion USD | 99.898% |
| Cellectis S.A. | 333.99 Million USD | 88.369% |